LLY

Eli Lilly and Company

879.14 USD
+0.70 (+0.08%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Eli Lilly and Company stock is up 14.01% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 64% of the previous 49 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
14 Jun 19:40 14 Jun, 2024 865.00 CALL 25 434
14 Jun 19:40 20 Sep, 2024 860.00 CALL 10 221
14 Jun 19:40 28 Jun, 2024 860.00 CALL 10 637
14 Jun 19:43 14 Jun, 2024 490.00 CALL 6 8
14 Jun 19:43 17 Jan, 2025 900.00 PUT 5 116
14 Jun 19:43 28 Jun, 2024 490.00 CALL 6 0
14 Jun 19:44 28 Jun, 2024 520.00 CALL 10 0
14 Jun 19:57 19 Jul, 2024 900.00 CALL 30 1118
14 Jun 19:58 16 Aug, 2024 820.00 CALL 4 1155
14 Jun 19:59 16 Jan, 2026 920.00 CALL 2 528

About Eli Lilly and Company

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic colorectal cancer, and hepatocellular carcinoma. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic ax

  • Cantor Fitzgerald
    Tue Jun 11, 12:25
    buy
    confirm
  • Jefferies
    Fri Jun 7, 13:25
    buy
    confirm